Protocols

Blinded design of clinical studies of drugs

Summary

Blinding (blinding, masking) refers to the clinical trials of drugs, in order to avoid the researcher and/or the subject to know the type of drug used in different test groups and the evaluation of a method of influence (bias). Blinding is mainly categorized into Single Blind Trial (Single Blind Trial), Double Blind Trial (Double Blind Trial) and Double Blind, Double Dummy Trial (Double Blind, Double Dummy Trial).


For more product details, please visit Aladdin Scientific website.

https://www.aladdinsci.com/

Categories: Protocols
Explore topics: Laboratory animal

Da — when not otherwise indicated, molecular weight units are daltons.   Mw — weight-average molecular weight.   Mn — number-average molecular weight.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Cite this article

Aladdin Scientific. "Blinded design of clinical studies of drugs" Aladdin Knowledge Base, updated Dec 24, 2024. https://www.aladdinsci.com/us_en/faqs/blinded-design-of-clinical-studies-of-dr-en.html
Was this article helpful? Yes No 3 out 5 found this helpful

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.